AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,283,000 | +53.0% | 78,335 | +4.6% | 0.01% | +20.0% |
Q4 2018 | $3,454,000 | -70.0% | 74,907 | -49.9% | 0.01% | -28.6% |
Q3 2018 | $11,530,000 | +80.8% | 149,518 | +97.5% | 0.01% | -12.5% |
Q2 2018 | $6,376,000 | +7.9% | 75,695 | +4.8% | 0.01% | 0.0% |
Q1 2018 | $5,909,000 | +92.9% | 72,256 | +34.8% | 0.01% | +100.0% |
Q4 2017 | $3,064,000 | -2.8% | 53,591 | +13.5% | 0.00% | 0.0% |
Q3 2017 | $3,152,000 | +31.1% | 47,216 | +1.0% | 0.00% | +33.3% |
Q2 2017 | $2,404,000 | +36.0% | 46,733 | +54.4% | 0.00% | 0.0% |
Q1 2017 | $1,767,000 | +43.1% | 30,258 | +2.3% | 0.00% | +50.0% |
Q4 2016 | $1,235,000 | -3.1% | 29,592 | +22.7% | 0.00% | 0.0% |
Q3 2016 | $1,274,000 | +31.2% | 24,125 | +4.0% | 0.00% | 0.0% |
Q2 2016 | $971,000 | +23.9% | 23,186 | +20.1% | 0.00% | +100.0% |
Q1 2016 | $784,000 | -37.4% | 19,300 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $1,253,000 | -6.4% | 19,300 | +1.8% | 0.00% | -33.3% |
Q3 2015 | $1,338,000 | -33.8% | 18,955 | +4.2% | 0.00% | -25.0% |
Q2 2015 | $2,021,000 | -5.6% | 18,185 | -19.9% | 0.00% | 0.0% |
Q1 2015 | $2,140,000 | -3.9% | 22,697 | +14.2% | 0.00% | 0.0% |
Q4 2014 | $2,227,000 | +91.3% | 19,877 | +4.7% | 0.00% | +100.0% |
Q3 2014 | $1,164,000 | +33.8% | 18,977 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $870,000 | +133.2% | 18,977 | +99.3% | 0.00% | +100.0% |
Q1 2014 | $373,000 | +63.6% | 9,520 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $228,000 | -14.3% | 9,520 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $266,000 | – | 9,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |